ライフサイエンスコーパス: any of the following

1 n was blocked when we added neutralizing antibodies against any of the following: 1) laminin (specifically laminin-1), 2)

2 spitalization within the previous 36 h, active dyspnea, and any of the following: 1) estimated glomerular filtration rate

3 s were defined according to currently consented criteria as any of the following: shortest preexcited RR interval during

4 rest was a documented limitation in life support defined as any of the following: 1) no cardiopulmonary resuscitation, 2)

5 MET-driven PRCC was defined as any of the following: chromosome 7 copy gain, focal MET or HG

6 absence of a major adverse cardiovascular event, defined as any of the following: death, cardiopulmonary resuscitation, m

7 Asthma exacerbations were defined as any of the following: prescription for oral corticosteroids,

8 -epidermal separation was significantly reduced by blocking any of the following: Fcgamma receptor binding (P = 0.048), e

9 ary outcome was a composite of treatment failure defined by any of the following occurring within 7 days of enrollment: i

10 ndpoint was the number of hypotensive events, as defined by any of the following: decrease in systolic blood pressure gre

11 y outcome was biochemical-clinical failure (BCF) defined by any of the following: PSA failure (nadir + 2), hormonal inter

12 participants) from 1991 up to Nov 30, 2007, which compared any of the following antidepressants at therapeutic dose rang

13 ies, the primary composite measure of HI-EOL care comprised any of the following: intravenous chemotherapy < 14 days from

14 A analysis failed to detect mutations in the genes encoding any of the following proteins: AChR subunits, rapsyn, ColQ, C

15 ntified, within each subsample, persons who had experienced any of the following triggers for violent acts between Januar

16 physician or outpatient claims at least 30 days apart--for any of the following diagnoses: ischemic and thrombotic event

17 rtality held in multivariate modeling after controlling for any of the following individually: PaO2/FIO2, oxygenation ind

18 Similarly, there were no significant differences for any of the following secondary outcome measures: mean total p

19 ssociated with mortality after controlling individually for any of the following in multivariate models: PaO2/FIO2, oxyge

20 inics if they had no history of atrial fibrillation but had any of the following: CHA2DS2-VASc score of >/=2, sleep apnea

21 Complex lesions had any of the following characteristics: unprotected left main,

22 Worth area from 2016 to 2019 to locate ED patients who had any of the following: D-dimer, CTPA, scintillation ventilatio

23 omavirus-positive patients (n = 943) were defined as having any of the following: a kidney biopsy with PV associated neph

24 Positive depression status was defined as having any of the following: elevated depressive symptoms, antidepre

25 Patients were eligible if any of the following requirements were satisfied: (1) Gleason

26 years, the treatment strategy was classified as "failed" if any of the following were met, both with and without correcti

27 ously validated morbidity-mortality composite that included any of the following events following surgery before discharg

28 come was defined as mortality or major morbidity, including any of the following: persistent periventricular echogenicity

29 tracorporeal treatment: Severe methanol poisoning including any of the following being attributed to methanol: coma, seiz

30 Hypermethylation of any of the following, p15, p16, CACNA1G, MINT1, MINT2, MDR1,

31 Inhibition of any of the following can suppress formation of lipid droplets

32 all-cause mortality and (2) time to the first occurrence of any of the following events: cardiac death, ischemic stroke,

33 The composite primary end point was the first occurrence of any of the following events: sudden cardiac death, sustained

34 The primary end point was the first occurrence of any of the following: new diagnosis of coronary artery diseas

35 Severe organ involvement was defined as the presence of any of the following: 1) in the kidney, scleroderma "renal cr

36 eurodevelopmental impairment was defined as the presence of any of the following: moderate to severe cerebral palsy, a co

37 Six- and 12-month follow-up reports on use of any of the following tobacco products within the prior 6 mont

38 ngth-for-age or height-for-age Z scores (LAZ or HAZ) and on any of the following outcomes: motor, cognitive or mental, la

39 There was no difference between the groups on any of the following measures: episodes of incontinence decre

40 T was defined as any further glaucoma procedure post-SLT or any of the following at 2 consecutive visits: IOP >21 mmHg, I

41 When considered separately, any of the following-intracranial pressure >25 mm Hg, mean ar

42 Patients aged 65 or older who underwent any of the following general elective surgeries: abdominal ao

43 The primary endpoint was any of the following: stroke or death within 30 days after en

44 Invasive CA was performed when any of the following were present: coronary anatomy at CTCA w

45 We first identified patients with CLD (n = 1565) with any of the following clinical characteristics: ascites, esoph

46 d when primary cultured rat hepatocytes were cotreated with any of the following agents that inhibit steps upstream of cy

47 Patients with any of the following characteristics were eligible for study

48 was defined as a composite of all patients presenting with any of the following outcomes: radiological objective respons

49 eath, and congenital defects in pregnant women treated with any of the following: 1) a vitamin K antagonist (VKA) through

50 Survival to discharge and survival without any of the following adverse outcomes: grade III or IV intrav